Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Chronic Kidney Disease and Albuminuria in Children with Sickle Cell Disease
2011
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
2016
A Retrospective Review of Liver Transplant Patients Treated with Sirolimus from a Single Center: An Analysis of Sirolimus-Related Complications
2004
CKD: Common, Harmful, and Treatable—World Kidney Day 2007
2007
HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients
2005
Acute kidney injury
2012 Standout
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
CKD Prevention in Sub-Saharan Africa: A Call for Governmental, Nongovernmental, and Community Support
2008
Variation in the serum creatinine assay calibration: A practical application to glomerular filtration rate estimation
2005
Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease
2008
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States
2011
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey
2002 Standout
Class Switch Recombination and Somatic Hypermutation in Early Mouse B Cells Are Mediated by B Cell and Toll-like Receptors
2007 StandoutNobel
Effect of Pravastatin on Loss of Renal Function in People with Moderate Chronic Renal Insufficiency and Cardiovascular Disease
2003
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Prevalence of Kidney Damage in Australian Adults
2003
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Traditional Cardiac Risk Factors in Individuals with Chronic Kidney Disease
2003
Cancer after Kidney Transplantation in the United States
2004
Impact of Creatinine Calibration on Performance of GFR Estimating Equations in a Pooled Individual Patient Database
2007
Chronic Kidney Disease and Mortality Risk
2006
Management of Sepsis
2006
Steroid-free Immunosuppression in Kidney Transplantation: An Editorial Review
2002
Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality
2004
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Community-based screening for chronic kidney disease among populations older than 40 years in Beijing
2007
Hypertensinogenic mechanism of the calcineurin inhibitors
2002
Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort
2008
Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi
2010
The Aging Kidney: A Review – Part I
2005
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement
2002
Intracellular Toll-like Receptors
2010 StandoutNobel
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Chronic kidney disease
2011 Standout
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
Kidney function and discrimination of cardiovascular risk in middle‐aged men
2009
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Current Status and Future Perspectives for CKD Testing
2009
Screening for Proteinuria in US Adults
2003
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
2010
Dissecting and refining the staging of chronic kidney disease
2009
Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis
2017
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2005 Standout
Frailty and chronic kidney disease: A systematic review
2016
Sirolimus increases transforming growth factor-β1 expression and potentiates chronic cyclosporine nephrotoxicity
2004
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Lifetime Incidence of CKD Stages 3-5 in the United States
2013
Conceptual Model of CKD: Applications and Implications
2009
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and Prevention
2009
Impact of renal failure on the risk of myocardial infarction and death
2002
Chronic kidney disease: global dimension and perspectives
2013 Standout
Detection of Chronic Kidney Disease With Laboratory Reporting of Estimated Glomerular Filtration Rate and an Educational Program
2004
Sickle-cell disease
2010 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Cardio-Kidney-Damage: a unifying concept
2010
Frailty: implications for clinical practice and public health
2019 Standout
Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease
2002
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Cardiovascular disease risk status in elderly persons with renal insufficiency
2002
Population based screening for chronic kidney disease: cost effectiveness study
2010
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis
2011
Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling
2002
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
An epidemic of chronic kidney disease: fact or fiction?
2007
The Aging Kidney: A Review – Part II
2005
The Hallmarks of Aging
2013 Standout
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
2001
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Evidence for increased cardiovascular disease risk in patients with chronic kidney disease
2003
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase
2009
Tumour necrosis factor and other cytokines in murine lupus
1999
Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
1991
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Chronic Kidney Disease
2016 Standout
Hypertension Following Kidney Transplantation
1994
Nephrology Visits and Health Care Resource Use Before and After Reporting Estimated Glomerular Filtration Rate
2010
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Early recognition and prevention of chronic kidney disease
2010
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
2005
The challenges of infection in transplantation: donor-derived infections
2005
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Overview
2002
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
2006 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation
2002
Detection and Awareness of Moderate to Advanced CKD by Primary Care Practitioners: A Cross-sectional Study From Italy
2008
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
Kidney Disease and Cardiovascular Risk
2006
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Estimation of Renal Function in Subjects With Normal Serum Creatinine Levels: Influence of Age and Body Mass Index
2005
Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease
2004
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
2005
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Works of Bryce Kiberd being referenced
NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
2003
Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans
2002
CYCLOSPORINE-INDUCED RENAL DYSFUNCTION IN HUMAN RENAL ALLOGRAFT RECIPIENTS12
1989
Established murine lupus nephritis does not respond to exogenous interleukin-1 receptor antagonist; a role for the endogenous molecule?
1995
A PILOT STUDY OF STEROID-FREE IMMUNOSUPPRESSION IN THE PREVENTION OF ACUTE REJECTION IN RENAL ALLOGRAFT RECIPIENTS
2001
Quality of prereferral care in patients with chronic renal insufficiency
2002
Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation
2001
Classifying kidney problems: can we avoid framing risks as diseases?
2004
Guidelines for the treatment and management of new‐onset diabetes after transplantation1
2005
Screening for West Nile Virus in Organ Transplantation: A Medical Decision Analysis
2004
Treatment of lupus nephritis with total lymphoid irradiation. observations during a 12–79‐month followup
1988
Screening for Prostate, Breast and Colorectal Cancer in Renal Transplant Recipients
2003
Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III
2002
Frailty and Mortality in Dialysis
2015
The Chronic Kidney Disease Epidemic
2006
Cost-Effectiveness of Organ Donation: Evaluating Investment into Donor Action and Other Donor Initiatives
2004
CONVERSION TO RAPAMYCIN IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS: REPORT OF AN INITIAL EXPERIENCE1
2000
Relationship between Glomerular Filtration Rate and the Prevalence of Metabolic Abnormalities: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
2007
Slowing the progression of chronic renal insufficiency.
2002
Serum Creatinine in Patients with Advanced Liver Disease Is of Limited Value for Identification of Moderate Renal Dysfunction: Are the Equations for Estimating Renal Function Better?
2006
Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency
2003
Cumulative Risk for Developing End-Stage Renal Disease in the US Population
2002
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
2001
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
2001
IS 3-HOUR CYCLOSPORINE BLOOD LEVEL SUPERIOR TO TROUGH LEVEL IN EARLY POST-RENAL TRANSPLANTATION PERIOD?
2000
Albuminuria and renal insufficiency prevalence guides population screening
2003